-+ 0.00%
-+ 0.00%
-+ 0.00%

DUPIXENT® (DUPILUMAB) APPROVED IN JAPAN FOR CHILDREN AGED 6 TO 11 YEARS WITH BRONCHIAL ASTHMA

路透·12/23/2025 06:00:02

登录查看新闻详情